syngo DynaPBV BodyEvaluate perfusion for personalized therapy
syngo DynaPBV Body Video

syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany

syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany

syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body Video

syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany

syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany

syngo DynaPBV Body
Courtesy: Prof. Vogl, Dept. of Diagnostic and Interventional Radiology, University of Frankfurt, Germany
syngo DynaPBV Body Video



syngo DynaPBV Body is a 3D functional imaging application that provides physiological information directly in the interventional lab.
听
The software indicates the distribution of blood in lesions and surrounding tissue by means of color-coded cross-sectional blood volume maps. Based on this blood volume information, physicians can evaluate changes in perfusion caused by treatment or biological processes.
听
Features & Benefits

Features
- Shows the distribution and amount of blood in lesions
- Allows for blood volume measurements
- Provides physiological information directly in the angio suite
听

Benefits
- Determine the specific characteristics of each individual lesion
- Observe how tumor perfusion changes as a result of your therapy
- Control the optimal end point of your intervention
听
听
syngo DynaPBV Body Workflow
Clinical Use
Case Studies

Preparatory Arteriography for Isolation of the Hepatic Arterial Bed Prior to Radioembolization Therapy - Supported by syngo DynaPBV Body
Courtesy of Bora Peynircio臒lu, M.D.,
Associate Professor of Radiology, Department of Radiology, Hacettepe University Hospital, Ankara, Turkey

Transarterial Chemoembolization (TACE) in Multifocal Primary Liver Cancer - Supported by syngo DynaPBV Body
Courtesy of Philippe L. Pereira, M.D., PhD, EBIR, and Kristina Kr眉ger,
Department of Radiology, Minimally Invasive Therapies and Nuclear Medicine,
SLK Clinics GmbH, Heilbronn, Germany

Hepatic Blood Volume Imaging Within Catheter Labs - Supported by syngo DynaPBV Body
Courtesy of Prof. Xu Jianrong, M.D.
Department of Radiology, Renji Hospital, China
Protocols and Sequences

Transarterial chemoembolization of HCC using syngo DynaPBV Body
51-year-old male with Hep C. Hepatocellular BCLC stage A carcinoma (HCC), which is not amenable to radiofrequency (RF) ablation due to its proximity to the gall bladder. Patient is awaiting liver transplant and recommended for TACE treatment.
Scientific Talks and Publications
General Requirements
System
- Artis Q
- Artis zee
Minimum Software Version
PURE庐
Other
Please note: Additional technical prerequisites may apply. Upon receiving your request, your local Siemens representative will clarify whether your system meets the requirements.
Did this information help you?
Thank you.
The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.